Growth Metrics

Fulgent Genetics (FLGT) Non-Current Debt (2021 - 2026)

Fulgent Genetics' Non-Current Debt history spans 6 years, with the latest figure at $1.5 million for Q1 2026.

  • On a quarterly basis, Non-Current Debt fell 24.62% to $1.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 million, a 24.62% decrease, with the full-year FY2025 number at $2.0 million, down 21.46% from a year prior.
  • Non-Current Debt hit $1.5 million in Q1 2026 for Fulgent Genetics, down from $2.0 million in the prior quarter.
  • Over the last five years, Non-Current Debt for FLGT hit a ceiling of $3.4 million in Q4 2022 and a floor of $1.5 million in Q1 2026.
  • Historically, Non-Current Debt has averaged $2.3 million across 5 years, with a median of $2.5 million in 2024.
  • Biggest five-year swings in Non-Current Debt: dropped 12.1% in 2023 and later fell 24.62% in 2026.
  • Tracing FLGT's Non-Current Debt over 5 years: stood at $3.4 million in 2022, then dropped by 12.1% to $3.0 million in 2023, then fell by 15.89% to $2.5 million in 2024, then fell by 21.46% to $2.0 million in 2025, then fell by 24.62% to $1.5 million in 2026.
  • Business Quant data shows Non-Current Debt for FLGT at $1.5 million in Q1 2026, $2.0 million in Q4 2025, and $2.0 million in Q3 2025.